Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01185 (
vasopressin
)
23,126
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The concentrations of
vasopressin
in the plasma and cerebrospinal fluid (CSF) of the chronically catheterized fetal lamb were measured under basal and hypoxic conditions. Under basal conditions, samples were obtained from 13 fetal lambs of 117-146 days gestation. The mean +/- SEM
vasopressin
level in CSF was 19.5 +/- 1.5 pg/ml; the mean plasma
vasopressin
level of 1.9 +/- 0.2 pg/ml was significantly less (P less than 0.001). No consistent change in concentrations of
vasopressin
in CSF was observed with gestational maturation in 3 animals sampled sequentially or in individual samples obtained over the last 32 days of gestation. The mean
vasopressin
concentration in the CSF of the pregnant ewe was 5.1 +/- 0.4 pg/ml. The gradients for osmolality, sodium, and potassium between fetal plasma and CSF were: osmolality, 298.4 +/- 1.6 to 304.3 +/- 1.4 mosmol/kg; sodium, 140.9 +/- 0.5-142.5 +/- 0.5 meq/liter; and potassium, 4.3 +/- 0.1 to 3.3 +/- 0.1 meq/liter.
Fetal hypoxia
was induced by exposure of the ewe to 10% O2 in N2 for 30 min. The concentration of
vasopressin
increased from 1.7 +/- 0.3 to 277 +/- 144 pg/ml (P less than 0.001) in fetal plasma and from 21.4 +/- 3.8 to 47.1 +/- 9.9 pg/ml (P less than 0.04) in fetal CSF. When the ewe was exposed to room air under comparable experimental conditions, no similar changes in plasma or CSF
vasopressin
levels were observed in the fetus. Infusion of
vasopressin
into the fetal jugular vein at 1.0 mU/min for 30 min increased plasma concentrations from 2.3 +/- 0.5 to 83 +/- 17 pg/ml, while the CSF
vasopressin
values were 31.9 +/- 5.9 (basally) and 30.7 +/- 4.8 pg/ml (after infusion). Mean plasma and CSF osmolality, sodium, and potassium were not changed by any of these experimental interventions. We conclude that 1) under basal conditions, high concentrations of
vasopressin
are present in the CSF of the fetal lamb, the blood-CSF barrier appears to be impermeable to
vasopressin
, and concentrations of the hormone in fetal plasma are less than those in CSF; and 2) hypoxia is a potent stimulus of
vasopressin
release in both fetal plasma and CSF. The route of
vasopressin
released into the fetal CSF may be distinct from that released into plasma.
...
PMID:Cerebrospinal fluid and plasma vasopressin in the fetal lamb: basal concentration and the effect of hypoxia. 396 53
Hypoxia is a potent stimulus to the release of
vasopressin
in fetal sheep, and plasma concentrations of the hormone correlate inversely with fetal oxygenation. Since the fetal kidney contributes to
vasopressin
clearance, we propose that measurement of increased amounts of
vasopressin
in amniotic fluid would be indicative of
fetal hypoxia
. Therefore, we measured concentrations of
vasopressin
in amniotic fluid under resting conditions, during and after
fetal hypoxia
, and with intravenous and intra-amniotic administration of
vasopressin
in 15 chronically instrumented fetal lambs between 111 and 141 days gestation. In the resting state, mean (+/- SE)
vasopressin
concentrations in amniotic fluid (1.6 +/- 0.3 pg ml-1) did not differ from those in maternal (1.4 +/- 0.4 pg ml-1) or fetal (1.8 +/- 0.2 pg ml-1) plasma. Following exposure of the ewe to 10% O2 or partial occlusion of the umbilical cord,
vasopressin
concentrations in fetal plasma increased significantly (P less than 0.001) to 200 +/- 59 pg ml-1 with a delayed increase in amniotic fluid concentrations (P less than 0.03) to 15.8 +/- 4.5 pg ml-1. This rise in concentration of
vasopressin
in amniotic fluid was sustained for at least 24 h and levels at that time were highly correlated with peak plasma concentrations (r = 0.83; P less than 0.001). Intravenous infusion of
vasopressin
into the fetus was accompanied by an equally significant (P less than 0.02) and sustained increase of
vasopressin
in amniotic fluid. Following intra-amniotic injection of
vasopressin
, levels remained increased for at least 24 h.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Vasopressin concentration in amniotic fluid as an index of fetal hypoxia: mechanism of release in sheep. 648 6
Hypoxia is a potent stimulus to the release of
vasopressin
in fetal sheep and, in turn, plasma concentrations of the hormone correlate inversely with fetal oxygenation. Because the fetal kidney contributes to
vasopressin
clearance, we propose that measurement of increased amounts of
vasopressin
in amniotic fluid would be indicative of
fetal hypoxia
. We therefore measured concentrations of
vasopressin
in amniotic fluid under resting conditions, during and after
fetal hypoxia
, and with intravenous and intra-amniotic administration of
vasopressin
in 15 chronically instrumented fetal lambs 111-141 d gestation. In the resting state mean (+/- SE)
vasopressin
concentrations in amniotic fluid (1.6 +/- 0.3 pg . ml-1) did not differ from those in maternal (1.4 +/- 0.4 pg . ml-1) or fetal (1.8 +/- 0.2 pg . ml-1) plasma. After exposure of the ewe to 10% O2 or partial occlusion of the umbilical cord,
vasopressin
concentrations in fetal plasma increased significantly (P less than 0.001) to 200 +/- 59 pg . ml-1 with a delayed increase in amniotic fluid concentrations (P less than 0.03) to 15.8 +/- 4.5 pg . ml-1. This rise in concentration of
vasopressin
in amniotic fluid was sustained for at least 24 h and levels at that time were highly correlated with peak plasma concentrations (r = 0.83, P less than 0.001). Intravenous infusion of
vasopressin
into the fetus was accompanied by an equally significant (P less than 0.02) and sustained increase of
vasopressin
in amniotic fluid. After intraamniotic injection of
vasopressin
, levels remained increased for at least 24 h.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Vasopressin concentration in amniotic fluid as an index of fetal hypoxia: mechanism of release in sheep. 673 95